|
![]() |
|||
|
||||
OverviewGene transfer research is a rapidly advancing field that involves the introduction of a genetic sequence into a human subject for research or diagnostic purposes. Clinical gene transfer trials are subject to regulation by the U.S. Food and Drug Administration (FDA) at the federal level and to oversight by institutional review boards (IRBs) and institutional biosafety committees (IBCs) at the local level before human subjects can be enrolled. In addition, at present all researchers and institutions funded by the National Institutes of Health (NIH) are required by NIH guidelines to submit human gene transfer protocols for advisory review by the NIH Recombinant DNA Advisory Committee (RAC). Some protocols are then selected for individual review and public discussion. Oversight and Review of Clinical Gene Transfer Protocols provides an assessment of the state of existing gene transfer science and the current regulatory and policy context under which research is investigated. This report assesses whether the current oversight of individual gene transfer protocols by the RAC continues to be necessary and offers recommendations concerning the criteria the NIH should employ to determine whether individual protocols should receive public review. The focus of this report is on the standards the RAC and NIH should use in exercising its oversight function. Oversight and Review of Clinical Gene Transfer Protocols will assist not only the RAC, but also research institutions and the general public with respect to utilizing and improving existing oversight processes. Table of Contents Front Matter Summary 1 Introduction 2 Gene Transfer Research: The Evolution of the Clinical Science 3 Oversight of Gene Transfer Research 4 Evolution of Oversight of Emerging Clinical Research Appendix A: Data Sources and Methods Appendix B: Historical and Policy Timelines for Recombinant DNA Technology Appendix C: Committee Biographies Full Product DetailsAuthor: Institute of Medicine , Board on Health Sciences Policy , Committee on the Independent Review and Assessment of the Activities of the NIH Recombinant DNA Advisory Committee , Lawrence O. GostinPublisher: National Academies Press Imprint: National Academies Press Dimensions: Width: 15.20cm , Height: 1.00cm , Length: 22.90cm Weight: 0.218kg ISBN: 9780309296625ISBN 10: 0309296625 Pages: 134 Publication Date: 27 April 2014 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of Contents1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 Gene Transfer Research: The Evolution of the Clinical Science; 5 3 Oversight of Gene Transfer Research; 6 4 Evolution of Oversight of Emerging Clinical Research; 7 Appendix A: Data Sources and Methods; 8 Appendix B: Historical and Policy Timelines for Recombinant DNA Technology; 9 Appendix C: Committee BiographiesReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |